• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

How's The Old New England Region Doing?

Ya. Its a real bastion of excess up here. What's that? No Harvard appointed doc can be a speaker? And that represents how many of the experts?

And don't forget the oodles of trials being run at our hospitals. Probably can count them using one finger.

How about Yale? How about the hospitals and teaching institutions in NE and parts of NY?
 












Ya. Its a real bastion of excess up here. What's that? No Harvard appointed doc can be a speaker? And that represents how many of the experts?

And don't forget the oodles of trials being run at our hospitals. Probably can count them using one finger.

Calm down and go have yourself a Sam Adams and lob-stah roll
 
















Here is how the game is played: when you get your butt kicked, you point to low access and that damned Hah-vid Pilgrim Health. But watch out for that once-in-blue-moon occurrence when they're on top.

Is it my imagination or has it become even harder so see people as of late and with Obamacare we are even more obsolete in Boston?
 




It's no secret that many big university hospitals are not rep-friendly. So the endo fellows come out of training thinking that we're Satan's spawn. Except for my friends in the South (and those that work at hospitals where we do studies), it seems that the fancier the hospital, the nastier they are towards us. er, umm or they WOULD be, if they took appointments.

Except the big hospitals in Boston still seem to take Big Pharma money in the millions if it helps them build and new building or R&D facility but that is done at the C level where it is all on the up and up. Right??